Targeted de-risking of specific R&D activities, access to clinical research facilities and provision of registration and market information can stimulate investment with positive Return on Investment (ROI) for animal health companies and other stakeholders. Animal health companies, international funding organizations, universities and research institutions will benefit from research and development outcomes when they access TAHSSL’s;